NEUP Neuphoria Total Business Assets
Neuphoria Therapeutics Inc. (NEUP) is implementing AI and robotics to automate the development of neuropreparations, minimizing the human factor in laboratories. This chart available on the page demonstrates the dynamics of total assets, which currently stand at 0.00. Neuphoria Therapeutics Inc. (NEUP) creates antidepressants through the precise modulation of brain ion channels. The business is currently focusing on molecule validation, which requires continuous funding to expand the pipeline.
Analytical breakdowns and data insights for company bionomics.com.au (NEUP)
- current price and projected stock value:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Neuphoria Therapeutics Inc.|NEUP - Long-Term Debt to Equity|Current Liabilities to Capital Neuphoria Therapeutics|NEUP - Company Debts|Debt to Book Value Ratio Neuphoria Therapeutics Inc.|NEUP - Company Long-Term Debts|Short-Term Debt Neuphoria Therapeutics|Quick Ratio bionomics.com.au
- company profitability and valuation multiples indicators:
Basic company analysis:Neuphoria
Neuphoria Therapeutics Inc. (NEUP) automates the creation of neuropreparations through AI and robotic bioscreening, which requires significant capital expenditures in technological infrastructure. The total value of resources, reverse-calculated via ROA, demonstrates a balance between equity and liabilities, allowing the investor to assess the stability of the base against external shocks across the trajectory of all company resources.
Direct competitors
Total Asset Value of Company BIIB (biogen.com)|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|Aggregate Company Assets Biohaven Ltd.|Total Business Assets AMLX (amylyx.com)|Company Total Assets TRVI|PRAX - Company Assets|Anavex Corp - Cumulative Company Assets|Company Total Assets CeriBell EEG CBLL|PRTA - Aggregate Company Assets|Total Asset Value of Company ALEC|ANNX: Company Total Assets|Omeros - Aggregate Asset Value|Aggregate Company Assets Neurogene Corp|Company Assets AC Immune Inc ACIU|Aggregate Company Assets Voyager Therapeutics (VYGR)|NMRA (neumoratx.com) - Aggregate Asset Value|Company Total Assets SCLX (Scilex)|Company Total Asset Base Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition Corp - Company Total Assets|CGTX - Company Total Assets|IKT (Inhibikase Therapeutics) - Cumulative Company Assets|cassavasciences.com - Aggregate Asset Value|Cumulative Company Assets ASRT|COYA (Coya) - Aggregate Business Assets|Company Total Assets VTGN|OVID (ovidrx.com) - Aggregate Asset Value|Company Total Assets ABOS (Acumen Pharmaceuticals)|cervomed.com (CRVO) - Company Assets|ATHE - Aggregate Company Assets|Aggregate Asset Value CLNN (Clene Inc.)|PEPG: Company Total Assets|Jupiter Neurosciences, Inc. (JUNS) - Company Total Assets|Aggregate Company Assets Relmada Therapeutics|annovisbio.com - Total Asset Value of Company|Company Total Assets GRCE|AIFF - Company Assets|Klotho Neurosciences - Cumulative Company Assets|Company Total Assets NeuroSense Therapeutics Ltd NRSN|RVPH: Cumulative Company Assets|MetaVia Inc - Aggregate Business Assets|NRXS: Company Total Assets|HSDT - Company Total Asset Base|PASG (Passage Bio Inc.) - Company Total Assets|Cumulative Company Assets Minerva (NERV)|Aggregate Company Assets Athira Pharma, Inc. (ATHA)|Company Total Asset Base addextherapeutics.com|Alzamend Neuro - Cumulative Company Assets|Aggregate Asset Value CYCN|Protagenic - Company Total Assets|Company Total Asset Base Pasithea Therapeutics KTTA|cortigent.com (CRGT) - Aggregate Company Assets|Total Business Assets ATXI|BCLI (BrainStorm Cell Therapeutics) - Company Total Assets|Cumulative Company Assets Cara Therapeutics Inc. (CARA)|Cumulative Company Assets CHRO (Chromocell Therapeutics Corporation)|Company Total Asset Base eliemtx.com|Aggregate Company Assets Intra-Cellular Therapies, Inc. ITCI|LBPH: Total Business Assets|Marinus Pharmaceuticals, Inc. - Company Total Assets|Company Assets NKGen Biotech Inc|NRBO (NeuroBo) - Cumulative Company Assets|Sage Therapeutics Inc (SAGE) - Company Total Assets|Aggregate Company Assets Synaptogenix, Inc.|trevena.com - Total Asset Value of Company|Aggregate Company Assets Vigil Neuroscience (VIGL)|anewmeds.com - Total Business Assets|Company Total Assets CERE (Cerevel)